本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

529.97
-4.5250-0.85%
成交量:3.60萬
成交額:1,922.79萬
市值:122.19億
市盈率:-37.28
高:540.00
開:540.00
低:527.97
收:534.49
52周最高:615.00
52周最低:393.61
股本:2,305.55萬
流通股本:1,372.50萬
量比:0.76
換手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
淨資產收益率:-53.31%
總資產收益率:-17.84%
市淨率:23.33
市盈率(LYR):-41.24

資料載入中...

2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities